Dive Brief: The Food and Drug Administration on Wednesday approved AstraZeneca and Merck & Co.’s Lynparza for use in certain people newly diagnosed with advanced prostate …
Sanofi on Wednesday said an experimental multiple sclerosis drug succeeded in a mid-stage trial, giving the company the confidence to bring the medicine into pivotal …
Dive Brief: Medicare on Thursday affirmed plans to limit coverage for certain Alzheimer’s disease drugs, but signaled it’s taking steps to ensure broader access should …
Moderna said Friday that one of its rare disease drug programs showed promise in its first clinical trials, according to an early look at the …
The race to develop the next blockbuster anti-inflammatory disease drug is heating up. In recent months, Merck & Co. and Pfizer have both made moves …
The Supreme Court on Thursday ruled against Amgen in its decade-long battle with Sanofi and Regeneron, affirming a lower court’s decision that Amgen’s rivals did …
Advisers to the Food and Drug Administration on Friday recommended against approving an experimental drug for a common fatty liver disease called NASH, increasing the …
We are proud to launch SGS PACE. Bringing the vision of your drug to life, SGS PACE is a unique, streamlined pathway to accelerate molecules …
A group of Food and Drug Administration advisers narrowly supported approving what could be the first gene therapy for Duchenne muscular dystrophy in a meeting …
Amylyx Pharmaceuticals has again impressed Wall Street, disclosing Thursday a new earnings report in which product revenue was significantly higher than many analyst forecasts. The …
An experimental vaccine developed by German drug developer BioNTech showed early promise in a small study of people with pancreatic cancer, suggesting that personalized immunotherapy …
Dive Brief: Gilead Sciences on Tuesday said it has acquired the privately held biotechnology company XinThera for an undisclosed sum, gaining access to a slate …
The European Laboratory Research & Innovation Group (ELRIG) UK today announced the appointment of Nick Clare to the ELRIG board. He will chair and lead …
New equipment added to San Diego and Melbourne facilities will help with clinical scale and global capacity shortages PCI Pharma Services (PCI), a leading global …
The cancer cell therapy Carvykti dramatically outperformed standard drugs in a late-stage clinical trial testing its use in earlier treatment of the blood cancer multiple …
At least five dozen biotechnology companies have laid off employees so far this year in a sector-wide contraction that has reached large and small drugmakers …
In the latest setback for ALS research, Apellis Pharmaceuticals, a Massachusetts-based drug company, has discontinued a portion of a key clinical trial testing one of …
Biotech Fluidics announce REFRACTiMASTER® – a new HPLC refractive index (RI) detector suitable for detecting compounds with little or no UV activity including simple sugars, …
An experimental vaccine may help stop tumors from recurring in people with a common form of skin cancer, detailed results from a mid-stage study run …
At least five dozen biotechnology companies have laid off employees so far this year in a sector-wide contraction that has reached large and small drugmakers …
